Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years-Reference-Cited by-同舟云学术

Receipt of BNT162b2 Vaccine and COVID-19 Ambulatory Visits in US Children Younger Than 5 Years

Published:2023-10-03 Issue:13 Volume:330 Page:1282
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Tartof Sara Y.¹,Frankland Timothy B.²,Slezak Jeff M.¹,Puzniak Laura³,Ackerson Bradley K.⁴,Jodar Luis³,McLaughlin John M.³

Affiliation:

1. Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena

2. Kaiser Permanente Hawai‘i Center for Integrated Health Care Research, Honolulu, Hawai‘i

3. Pfizer Inc, Collegeville, Pennsylvania

4. Southern California Permanente Medical Group, Harbor City

Abstract

This study examines the association of the receipt of wild-type BNT162b2 vaccine with medically attended COVID-19 outcomes among children younger than 5 years in the US.

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2809748/jama_tartof_2023_ld_230064_1696283268.43113.pdf

Reference6 articles.

1. Interim recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years: United States, June 2022.;Fleming-Dutra;MMWR Morb Mortal Wkly Rep,2022

2. Preliminary estimates of effectiveness of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection among children aged 3-5 years: increasing community access to testing program, United States, July 2022-February 2023.;Fleming-Dutra;MMWR Morb Mortal Wkly Rep,2023

3. Effectiveness associated with BNT162b2 vaccine against emergency department and urgent care encounters for Delta and Omicron SARS-CoV-2 infection among adolescents aged 12 to 17 years.;Tartof;JAMA Netw Open,2022

4. Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age.;Muñoz;N Engl J Med,2023

5. Centers for Disease Control and Prevention. COVID-19 vaccination coverage and vaccine confidence among children: COVIDVaxView. Accessed May 25, 2023. https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/children.html

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review;Vaccines;2024-08-29

2. COVID-19 Vaccine Hesitancy in Caregivers of Hospitalized Children From 2020 Through 2023;Hospital Pediatrics;2024-08-05

3. Estimated Effectiveness of the BNT162b2 XBB Vaccine Against COVID-19;JAMA Internal Medicine;2024-08-01

4. CoVacU18-Study: Long-Term Safety of BNT162b2 in Children under 18 Years in Germany;2024-07-10

5. BNT162b2 XBB1.5-adapted Vaccine and COVID-19 Hospital Admissions and Ambulatory Visits in US Adults;2023-12-28